This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Aegerion Pharmaceuticals Inc. (cardiovascular and metabolic therapeutics) has netted just over $44mm through its initial public offering of 5mm common shares at $9.50 each, well below the $14-16 range the company had expected.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?